Even though the first release of IDAAPM includes experimental and calculated physico-chemical properties, we aim to include additional molecular properties.
Moreover, we aim to include all compounds in advanced clinical trials, as this is highly relevant in the context of drug discovery.
If we aim to include all immigrants who stay in the Netherlands temporarily and for a rather short period, such as seasonal workers in the agricultural economy, we may use the RNI and WNB.
Moreover, we aim to include species other than human, as well as protein expression levels for diseased tissues, as this is highly relevant in the context of drug discovery.
While similar approaches such as [36] and [37] only utilize positional priors, we aim to include additional constraints, e.g., the anatomical context or the epipolar geometry of the camera setup.
In particular, we aim to include enough information to support consistency checking and design coherence, as described in the discussion section.
We aim to include 240 parents.
We aim to include N=414 participants.
We aim to include all alters of health care professionals.
Therefore, we aim to include 115 dyads per country in this setting.
We aim to include 44 children per hospital into the study.
